BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 31749082)

  • 1. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
    Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
    Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
    Elbasan O; Ilgın C; Gogas Yavuz D
    Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
    Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
    Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
    Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
    Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.
    Pyo JS; Sohn JH; Kang G; Kim DH; Yun J
    Yonsei Med J; 2015 Mar; 56(2):355-61. PubMed ID: 25683981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocality related factors in papillary thyroid carcinoma.
    Gur EO; Karaisli S; Haciyanli S; Kamer E; Genc H; Atahan K; Haciyanli M
    Asian J Surg; 2019 Jan; 42(1):297-302. PubMed ID: 30585170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
    Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J
    Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
    Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
    Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
    Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
    Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
    Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
    World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
    J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
    Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.
    Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS
    ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.